These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 9794568

  • 1. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [Abstract] [Full Text] [Related]

  • 2. Sequential changes of biochemical bone parameters after kidney transplantation.
    Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K.
    Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Nov; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 5. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ, Bravo Soto JA, Merino Pérez MJ, González Carmelo I, López Jiménez V, García Álvarez T, Acosta Martínez Y, Mazuecos Blanca MA.
    Nefrologia; 2015 Nov; 35(4):363-73. PubMed ID: 26306956
    [Abstract] [Full Text] [Related]

  • 6. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C, Antonelli M, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005 Nov; 18(1):96-101. PubMed ID: 15772930
    [Abstract] [Full Text] [Related]

  • 7. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
    Boudville NC, Hodsman AB.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
    [Abstract] [Full Text] [Related]

  • 8. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI, Maestro ML, Calvo N, De La Orden V, Pérez Flores I, Vidaurreta M, Valero R, Fernández-Pérez C, Barrientos A.
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [Abstract] [Full Text] [Related]

  • 9. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients.
    Steiner RW, Ziegler M, Halasz NA, Catherwood BD, Manolagas S, Deftos LJ.
    Transplantation; 1993 Oct; 56(4):843-6. PubMed ID: 8212205
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
    Barros X, Rodríguez NY, Fuster D, Rodas L, Esforzado N, Mazza A, Rubello D, Campos F, Tapias A, Torregrosa JV.
    J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
    [Abstract] [Full Text] [Related]

  • 11. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [Abstract] [Full Text] [Related]

  • 12. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA, Booth BE, Halloran BP, Morris RC.
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [Abstract] [Full Text] [Related]

  • 13. Calcium and phosphorus metabolism in stable renal transplant recipients.
    Khosroshahi HT, Shoja MM, Azar SA, Tubbs RS, Safa J, Etemadi J, Ardalan MR.
    Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
    Sella S, Bonfante L, Fusaro M, Neri F, Plebani M, Zaninotto M, Aghi A, Innico G, Tripepi G, Michielin A, Prandini T, Calò LA, Giannini S.
    Clin Chem Lab Med; 2020 May 05; 59(2):343-351. PubMed ID: 32374278
    [Abstract] [Full Text] [Related]

  • 15. Influence of vitamin D on parathyroid function in the elderly.
    Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R.
    J Clin Endocrinol Metab; 1992 Aug 05; 75(2):494-501. PubMed ID: 1639950
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Jüppner H, Wolf M.
    Kidney Int; 2006 Oct 05; 70(8):1486-94. PubMed ID: 16941023
    [Abstract] [Full Text] [Related]

  • 17. Are plasma 1,25-dihydroxyvitamin D3 concentrations appropriate after successful kidney transplantation?
    Caravaca F, Fernández MA, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct 05; 13 Suppl 3():91-3. PubMed ID: 9568829
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
    Findling JW, Adams ND, Lemann J, Gray RW, Thomas CJ, Tyrrell JB.
    J Clin Endocrinol Metab; 1982 May 05; 54(5):1039-44. PubMed ID: 6977549
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.
    Clin Ther; 2014 May 05; 36(5):722-36. PubMed ID: 24802860
    [Abstract] [Full Text] [Related]

  • 20. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan 05; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.